|
⚲
|
| Keyboard |
| Stonepine Capital Management LLC
✚
|
|
|---|---|
| CRD # | 139891 |
| SEC # | 801-136874 |
| CIK # | 0001370042, 0001440771 |
| AUM | 181.0 M (2026-06-26) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Phone | 541-647-5673 |
| Address | 2900 NW Clearwater Drive Bend, OR 97703 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Verastem Inc | 17.5 | ||
| R&R Acquisition VI Inc | 17.0 | ||
| Oxygen Biotherapeutics Inc | 15.6 | ||
| Evolus Inc | 9.0 | ||
| Camp4 Therapeutics Corp | 6.1 | ||
| Nektar Therapeutics | 6.1 | ||
| Kempharm Inc | 4.5 | ||
| Access Pharmaceuticals Inc | 3.8 | ||
| Corbus Pharmaceuticals Holdings Inc | 3.6 | ||
| Establishment Labs Holdings Inc | 3.2 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Metolius Capital LP | [2017-03-30] | 7.9 M | 2.6 M |
| Filed 2018-12-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Finder's Fee $18,645 · Net Assets Decline to Disclose | ||||
| HF | Tumalo Capital LP | [2017-03-30] | 7.6 M | 2.5 M |
| Filed 2018-12-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Finder's Fee $23,449 · Net Assets Decline to Disclose | ||||
| HF | Stonepine Capital LP | 2015-03-24 | 181.0 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 1 | 181.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 1 | 181.0 |
| By Discretionary | ||
| Discretionary | 1 | 181.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 1 | 181.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 181.0 | |
| Total | 1 | 181.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Timothy Lynch | Executive Officer | 7 | 2 | |
| Matt Carroll | Executive Officer | 4 | 2 | |
| Jon Plexico | Executive Officer | 3 | 2 | |
| Stonepine Capital Management LLC | Executive Officer | 3 | 2 | |
| Jeff Nunnenkamp | Executive Officer | 3 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001370042] | |
| 4 | [0001370042] | |
| SC 13D | [0001370042] | |
| SC 13G | [0001370042] | |
| 13F-HR | [0001440771] | |
| 3 | [0001440771] | |
| 4 | [0001440771] | |
| SC 13G | [0001440771] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 213800AIP1E4A547KD30 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Chiasma Inc CHMA
Common Stock
|
2021-08-05 | Disposed to issuer | 6,770,000 | ||
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-12 | Buy | 1,000 | $0.70 | 700 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-11 | Buy | 40 | $0.69 | 28 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-10 | Buy | 5,202 | $0.69 | 3,589 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-09 | Buy | 4,500 | $0.70 | 3,150 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-06 | Buy | 40 | $0.70 | 28 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-05 | Buy | 5,160 | $0.70 | 3,612 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-11-22 | Buy | 89,845 | $0.75 | 67,384 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-10-11 | Buy | 100,000 | $0.65 | 65,000 |
|
Lpath Inc APEN
Warrant · derivative
|
2019-08-12 | Other | 1 | ||
|
Lpath Inc APEN
6.0% Convertible Debenture due 2024 · derivative
|
2019-08-12 | Buy | $2,775,000.00 | ||
|
Lpath Inc APEN
Common Stock
|
2019-08-12 | Other | 1,000,000 | ||
|
Lpath Inc APEN
Common Stock
|
2018-12-27 | Sell | 250,000 | $3.00 | 750,000 |
|
Lpath Inc APEN
Common Stock
|
2018-12-26 | Sell | 500,000 | $3.00 | 1,500,000 |
|
Lpath Inc APEN
Common Stock
|
2018-11-21 | Buy | 3,230 | $3.61 | 11,660 |
|
Lpath Inc APEN
Common Stock
|
2018-11-19 | Buy | 54,200 | $3.40 | 184,280 |
|
Lpath Inc APEN
Common Stock
|
2018-11-02 | Buy | 300,000 | $5.00 | 1,500,000 |
|
Lpath Inc APEN
Common Stock
|
2018-01-03 | Buy | 6,339 | $5.78 | 36,639 |
|
Lpath Inc APEN
Common Stock
|
2018-01-02 | Buy | 11,343 | $5.73 | 64,995 |
|
Lpath Inc APEN
Common Stock
|
2017-12-29 | Buy | 5,163 | $5.56 | 28,706 |
| showing 20 of 43 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
X Cubed Capital Management LLC
✚
|
MN | 184.0 M |
|
Open Door Investment Management Ltd
✚
|
CA | 183.4 M |
|
Smith Asset Management Group LP
✚
|
TX | 182.2 M |
|
Emmett Investment Management LP
✚
|
NY | 181.6 M |
|
Alpine Woods Capital Investors LLC
✚
|
NY | 180.6 M |
|
2E Capital Partners LP
✚
|
NY | 180.0 M |
|
Daventry Group LP
✚
|
NY | 179.9 M |
|
Arc24 Management LP
✚
|
NY | 179.7 M |
|
Gallo Partners LP
✚
|
179.0 M | |
|
Candelo Capital Management LP
✚
|
NY | 178.1 M |